These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2939454)

  • 1. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine.
    Hiestand PC; Mekler P; Nordmann R; Grieder A; Permmongkol C
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2599-603. PubMed ID: 2939454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the immunosuppressive properties of Sch 24937.
    Smith SR; Terminelli C; Epps S; Watnick A; Umland S
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):333-59. PubMed ID: 2963854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hypoprolactinemia alone and in combination with cyclosporine on allograft rejection.
    Wilner ML; Ettenger RB; Koyle MA; Rosenthal JT
    Transplantation; 1990 Feb; 49(2):264-7. PubMed ID: 1968297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A.
    Bernton E; Bryant H; Holaday J; Dave J
    Brain Behav Immun; 1992 Dec; 6(4):394-408. PubMed ID: 1336994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel immunosuppressant, IR-1116, which has a different biological mechanism from that of cyclosporine A.
    Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T
    Eur J Immunol; 1993 Sep; 23(9):2121-8. PubMed ID: 8370395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin receptors on human lymphocytes and their modulation by cyclosporine.
    Russell DH; Matrisian L; Kibler R; Larson DF; Poulos B; Magun BE
    Biochem Biophys Res Commun; 1984 Jun; 121(3):899-906. PubMed ID: 6331435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of immunological responsiveness to suppression of cellular responses by cyclosporine in vitro.
    MacSween JM; Cohen AD; Eastwood SL; Fernandez LA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1202-4. PubMed ID: 2978876
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
    Hess AD; Colombani PM
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro.
    Morikawa K; Oseko F; Morikawa S
    Clin Exp Immunol; 1994 Mar; 95(3):514-8. PubMed ID: 8137548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine.
    Russell DH; Kibler R; Matrisian L; Larson DF; Poulos B; Magun BE
    J Immunol; 1985 May; 134(5):3027-31. PubMed ID: 2984281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A.
    Morris PJ
    Transplantation; 1981 Nov; 32(5):349-54. PubMed ID: 6460358
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological studies on renal transplantation. III. Experimental studies on the immunosuppressive action of cyclosporin A].
    Matsuura T
    Nihon Hinyokika Gakkai Zasshi; 1984 Dec; 75(12):1857-65. PubMed ID: 6242058
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation.
    Carrier M; Wild J; Pelletier LC; Copeland JG
    Ann Thorac Surg; 1990 Jan; 49(1):129-32. PubMed ID: 2297260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of lymphokine responsiveness of hapten-specific B lymphocytes promoted through an antigen-mediated T helper lymphocyte interaction.
    Krusemeier M; Snow EC
    J Immunol; 1988 Jan; 140(2):367-75. PubMed ID: 2447174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid elevation of rat serum prolactin concentration by cyclosporine, a novel immunosuppressive drug.
    Cardon SB; Larson DF; Russell DH
    Biochem Biophys Res Commun; 1984 Apr; 120(2):614-8. PubMed ID: 6732774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses.
    Bowes LG; Dumble LJ; Francis DM; Macdonald IM; Clunie GJ; Kincaid-Smith P
    Transplant Proc; 1990 Oct; 22(5):2139-40. PubMed ID: 2145672
    [No Abstract]   [Full Text] [Related]  

  • 20. Resting lymphocytes are the target of cyclosporin action.
    Kimball PM; Gamaz N; Sell S
    Diabetes Res; 1988 Mar; 7(3):113-6. PubMed ID: 3262027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.